Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost

Phase 4

Completed

• Conditions: Glaucoma

• Registration Number: NCT00347841
• Lead Sponsor: Innovative Medical

Brief Summary

To evaluate the IOP-lowering efficacy of bimatoprost 0.03% in patients found to be low-responders to latanoprost therapy.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2006-06-30
• Study First Submitted QC: 2006-06-30
• Study First Posted: 2006-07-04
• Status Verified: 2007-05
• Last Update Submitted: 2007-05-30
• Last Update Posted: 2007-06-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• · Male or female > 18 years of age

  • Documented low-responder to latanoprost therapy as delineated in the outline above.
  • Diagnosis of open-angle glaucoma or ocular hypertension
  • Ability to provide informed consent and likely to complete all study visits

Exclusion Criteria

• · Known contraindication to bimatoprost or any component of any study medication

  • Uncontrolled systemic disease
  • Active ocular disease other than glaucoma or ocular hypertension
  • Required use of ocular medications other than the study medications during the study (intermittent use of artificial tear solutions will be permitted)
  • History of intraocular surgery within the last 3 months

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Trial Locations

Locations (1)

Dr. Noecker; 🇺🇸 Pittsburgh, Pennsylvania, United States